PINEHURST – A FirstHealth Moore Regional Hospital clinical trial is investigating whether the electrical treatment provided by a special type of pacemaker can keep a patient in heart failure from getting worse.
The Cardiac Resynchronization Therapy (CRT) pacemaker being studied in this clinical trial has been approved by the U.S. Food and Drug Administration (FDA) for patients with moderate to severe heart failure whose heart pumps blood inefficiently. The study will determine if blood can be pumped to the body more efficiently when the lower heart chambers (i.e. ventricles) are electrically paced to beat together by the CRT pacemaker.
Cardiac resynchronization therapy (CRT) can help restore a normal coordinated heart rhythm by delivering pacing treatment to both sides of the heart.
Participants in the trial will be men and women 18 years and older with a diagnosis of chronic heart failure. Pregnant women are not eligible.
Mark Landers, M.D., a cardiologist with FirstHealth Cardiology Services, is the principal investigator.
To refer a patient for this trial or for more information on patient eligibility, contact the FirstHealth Clinical Trials office at (910) 715-2200.